Recent Updates
Recently added Catalysts
PHGE Positive Sentiment Score: 65/100

BiomX to Host First Quarter 2023 Financial Results Conference Call and Webcast on May 15th, 2023

Monday, May 8, 2023 1 min read
Key Takeaway: BiomX Inc. has announced a conference call and audio webcast scheduled for May 15, 2023, at 8:00 a.m. ET to discuss its first quarter 2023 financial results and provide business updates. The company focuses on developing natural and engineered phage therapies aimed at treating chronic diseases by targeting specific bacteria. Stakeholders and interested parties are invited to participate in the call, and archived audio will be available on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • BiomX is advancing innovative therapies targeting pathogenic bacteria.
  • The company is hosting a conference call to update stakeholders on financial performance.
  • BiomX's approach involves custom phage compositions, showcasing their unique capabilities.

Full Press Release Details

CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 08, 2023 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the Company will host a conference call and a live audio webcast on Monday, May 15th, 2023, at 8:00 a.m. ET, to report first quarter 2023 financial results and provide business updates.
To participate in the conference call, please dial 1-877-407-0724 (U.S.) or 1-201-389-0898 (International). The live and archived webcast will be available in the Investors section of the Company’s website at www.biomx.com.
BiomX is a clinical-stage company developing both natural and engineered phage cocktails designed to target and destroy bacteria in the treatment of chronic diseases. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. For more information, please visit www.biomx.com.
Corporate Project Manager
LifeSci Advisors, LLC
jmullaly@lifesciadvisors.com

Frequently Asked Questions

What is BiomX's focus in biopharma?

BiomX specializes in natural and engineered phage therapies targeting pathogenic bacteria.

When will BiomX host its conference call?

The conference call will be on May 15th, 2023, at 8:00 a.m. ET.

How can I attend BiomX's conference call?

Dial 1-877-407-0724 for U.S. or 1-201-389-0898 for international participation.

Where can I find BiomX's financial results?

The financial results will be available in the Investors section on their website.

What does BiomX do with phage compositions?

BiomX customizes phage compositions to target and eliminate specific bacterial pathogens.

Tags: PHGE Viatris Investor Conferences Healthcare BiomX phage therapies chronic diseases financial results
Last updated: May 8, 2023